VLS Tirzepatide Pen

VLS Tirzepatide Prefilled Pen is a pharmaceutical-grade dual GLP-1/GIP receptor agonist in a convenient ready-to-use injection pen. This VLS Tirzepatide formulation offers researchers a high-purity compound for advanced studies in glycemic control, weight management, and metabolic health. Available in 20mg and 40mg variants with adjustable dosing. Independently lab-verified at 99.88% purity. Available for UK delivery with fast dispatch.

VLS Tirzepatide Research Benefits

Dual receptor action – Targets both GLP-1 and GIP receptors for comprehensive metabolic research
Glycemic control – Researched for enhancing insulin secretion and decreasing glucagon levels
Appetite regulation – Shows significant effects on hunger signalling and satiety pathways
Weight management – Investigated for substantial effects on body composition and weight loss
Convenient dosing – Prefilled pen with adjustable doses eliminates reconstitution and measuring

How VLS Tirzepatide Works

Tirzepatide is a dual agonist peptide that activates two key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-action approach enhances insulin secretion whilst decreasing glucagon levels.

The VLS Tirzepatide prefilled pen delivers this compound in a convenient, pre-mixed format with adjustable dosing. Research has demonstrated significant potential for improved glycemic control and weight management through the simultaneous targeting of both GLP-1 and GIP pathways.

💉 PEN DOSING INFORMATION

20mg Pen: Contains 20mg total in 3ml (6.66mg/ml). Delivers up to 4-20 doses depending on setting.

VLS Tirzepatide Pen

40mg Pen: Contains 40mg total in 3ml. Delivers up to 8-40 doses depending on setting.

VLS Tirzepatide Pen

Adjustable doses: Dial to 1mg, 2mg, 3mg, 4mg, or 5mg per injection as required for research protocol.

Included: 4 single-use disposable needles per box.

VLS Tirzepatide Pen vs Vials

The VLS Tirzepatide prefilled pen offers significant advantages over traditional vials requiring reconstitution. No bacteriostatic water needed, no measuring or calculations, and precise dial-a-dose functionality ensures consistent administration. The pen format also reduces contamination risk and provides extended stability compared to reconstituted solutions.

Why Choose VLS Tirzepatide?

VLS Pharmaceuticals produces pharmaceutical-grade peptides with exceptional purity and accurate dosing. The VLS Tirzepatide prefilled pen undergoes rigorous quality control and independent third-party testing through Janoshik laboratories, confirming 99.88% purity. This commitment to quality, combined with the convenience of the prefilled pen format, makes VLS Tirzepatide the preferred choice for metabolic research.